Data Analytics Content

Here you can find a comprehensive attendee profile of who attends Data Analytics for Pharma Development forum. This list is comprised of all attending accounts and job titles of attendees 

Ahead of the 5th Annual Data Analytics for Pharma Development Forum 2019, taking place on 12-14 November in Munich, we conducted an industry wide survey. In this infographic you will learn about the biggest challenges that are facing those using data analytics in their drug development, the strengths of using...

Ahead of the 5th Annual Data Analytics for Pharma Development Forum (Munich, 12-14thNovember 2019), we asked Nigel Hughes, Scientific Director at Janssen, to have a chat with us about the role of data analytics in the pharmaceutical industry and the impact AI & Machine Learning, RWD/RWE, GDPR and clinical trials...

Artificial Intelligence, Machine Learning and other technologies are expected to make the discovery and development of new pharmaceuticals quicker, cheaper and more effective. Download this article to hear experts insights from Leonardo Rodrigues, Senior Director, AI & Machine Learning at BERG Heath about how these tools will revolutionise drug development...

While most industries are already benefiting from better use of dataanalytics, Pharma has been slow to innovate their business mode and adopt new technologies. Pharma R&D is stalling, there is a cap onproductivity and companies need to leverage data insights to move forwards. With insights from Larry Pickett, CEO, RxDataScience,...

In this exclusive interview conducted ahead of this year’s forum for Data Analytics for Pharma Development, Paul Agapow, Health Informatics Director at AstraZeneca shares his views on the world of data, with a particular emphasise on how artificial intelligence (AI) can help analyse and interpret huge quantities of data at...

In this infographic experts provide insight on the opportunities that exist in big data analytics for Pharma and how pharma firms can capitalise on cracking open their data silos.

Big data has moved beyond the big hype. The data landscape in life sciences is changing rapidly, advancing technologies, pre-competitive data sharing and huge growth of structured and unstructured data volumes available to organisations are driving big data breakthroughs. Life science companies are looking for new ways to leverage big...

Thomas R. Ortiz, is the Chief Medical Officer at Reliance Medical Group, LLC and operates the Primary Care Medical Practices in five counties within New Jersey. In this interview, Ortiz says his business would do better with more organised data streams, which would improve overall outcomes and costs. Find out...

Big Data in healthcare delivery is really an illusion, according to Daniel Morreale, the Vice President and Chief Information Officer at Kingsbrook Jewish Medical Center. Other than large, academic medical centers, or medical giants such as Quest or Kaiser Permanente, a majority of big hospitals are doing very little with...

Real World Data can benefit multiple stakeholders within the value chain in order to support the commercialisation of strategies and provide insightful analysis for differentiation, to assist with regulatory submissions and to influence the market access strategies. However, it is not without its limitations and there a number of issues...

As of now, big data is not used as often and as well as it should be in the Pharmaceutical Industry.   Slowly the Industry is adopting data and analytics to improve itself. Data usage could lead to accelerated drug discovery, better help patients and predict emergency rush hours.  To keep...

Nigel Hughes, Director Integrative Healthcare Informatics, Janssen R&D, takes a closer look at how access to external data is critical in today’s world and the ways data accessibility can provide pharmaceutical companies with a competitive advantage. With large scale initiatives coming into practice, such as the European Medical Information Framework...

We caught up with Nigel Hughes, Scientific Director at Janssen, to explore the role of data analytics in the pharmaceutical industry, the challenges for those already working in data teams and the future of predictive analytics.

Allan Jordan strongly believes that while big data is important and can change pharma, it should not just be gathered without reason. There needs to be a purpose, and purpose is the main thing driving his latest project.  The project in question is focused on exploiting genome sequencing efforts to...

The biggest challenge life science companies now face is to learn how to use data, source of an enormous amount of information, and step out of the silos. Ahead of the third annual Data Analytics for Pharma Development, PharmaIQ had an exclusive interview Marie Montoya, CEO and Founder or M...